Resha Soni

Resha Soni practices at Aurora Cancer Care of Aurora Health Care Metro, Inc. - HOPD in Milwaukee, Wisconsin.

Resha Soni's NPI, 1366889156, was assigned on June 3, 2013. Resha Soni holds Wisconsin license 69072.

Resha Soni's primary practice is Aurora Cancer Care of Aurora Health Care Metro, Inc. - HOPD, at 3003 W Good Hope Rd, Milwaukee, WI 53209.

Resha Soni's primary practice is Aurora Cancer Care of Aurora Health Care Metro, Inc. - HOPD in Milwaukee, Wisconsin. Resha Soni is also affiliated with Aurora St. Luke's Medical Center. The medical group on file is Aurora Medical Group. Dmand AI also links Resha Soni to 2 more hospitals, 3 group practices and clinics, 2 medical groups, 1 breast imaging center and 1 clinical lab, each named with a free account. Resha Soni's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Resha Soni practices, 9 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Resha Soni's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Resha Soni's licenses on file in 2 states: Wisconsin and Pennsylvania.

CMS data shows 512 Medicare services from Resha Soni across 9 procedure codes in 2024, for 217 Medicare patients. Medicare paid $44,296 for them. Every service was in an office.

CMS counts 217 Medicare patients who saw Resha Soni in 2024. The largest group is 65 to 74, with 102 patients. 70% of them have high cholesterol, and 68% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Resha Soni's median patient age at 68, with 61% women.

In 2024, Resha Soni wrote 274 Medicare Part D claims for 124 patients. 96% of them were for generic drugs. CMS names the drug for 163 of them, across 7 drugs with 11 or more claims each, at $2,778 in total drug cost. In 2023, CMS named 103 claims across 4 drugs.

Resha Soni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Resha Soni as offering telehealth.

Dmand AI links 12 papers to Resha Soni, published from 2013 to 2020. 2017 was the busiest year, with 4. The most frequent topics are Dysphonia, Voice Quality and Disability Evaluation. Resha Soni has published most often in J Voice. Resha Soni's most frequent co-authors are Nausheen Jamal, MD, Seth H. Dailey, MD and Jean Anderson A. Eloy, MD.

CMS Open Payments shows 8 general payments to Resha Soni from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $258.